Interleukin-35; as a Novel Immuno-biomarker in Epilepsy
- سال انتشار: 1398
- محل انتشار: شانزدهمین کنگره بین المللی صرع
- کد COI اختصاصی: EPILEPSEMED16_052
- زبان مقاله: انگلیسی
- تعداد مشاهده: 514
نویسندگان
MD, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Associate professor of immunology, Department of Immunology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Cancer Gene Therapy Research Center (CGRC), Zanjan University of Medical Sciences, Zanjan, Iran.
چکیده
Background: The occurrence of the recurrent seizures is termed as epilepsy. The neurobiology mechanisms of epilepsy is inflammation and alteration in permeability of the blood-brain barrier. Inflammation can lead to synaptic changes and neuronal hyper-excitability. Besides pro-inflammatory cytokines, anti-inflammatory cytokines exist in epileptogenic microenvironment. Interleukin-35 (IL-35) is one of the latest anti-inflammatory cytokines in immunology field. The purpose of this study was to perform systematic review to determine the role of IL-35 in epilepsy development. Methods: This systematic review was performed to identify studies that were published in Pubmed, ScienceDirect, Scopus databases and Google Scholar search engine, in 2010 - October 2019 time interval by using 4 keywords (Epilepsy, Immuno-biomarker, Interleukin-35, and Inflammation). Of the 96 articles initially identified based on inclusion criteria, 35 were selected based on our exclusion criteria. Findings: Documents have revealed the high levels of pro-inflammatory cytokines such as IL-1B, IL-6 in neuronal epileptogenic brain tissue. It is better to say that if the condition led toward anti-inflammatory state, severity of the epilepsy, and patient prognosis would be more desirable. According to accumulative data, the levels of IL-35 in epileptogenic environment has a negative correlation with the severity of the epilepsy. Conclusion: In attention to the inflammation in epileptogenic environment, high expression of IL-35 may cause less neuronal damage following seizure and improve the prognosis. Also, IL-35 could be as an immunological target in the treatment of the refractory epileptic patients.کلیدواژه ها
Epilepsy, Immuno-biomarker, Interleukin-35, Inflammation.مقالات مرتبط جدید
اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.